Associations between CD36 gene polymorphisms and susceptibility to coronary artery heart disease

Brazilian Journal of Medical and Biological Research

Volumn 47, Issue 10, 2014, Pages 895-903

  Zhang, Y ^a   Ling, Z Y ^a   Deng, S B ^a   Du, H A ^a   Yin, Y H ^a   Yuan, J ^a   She, Q ^a   Chen, Y Q ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

CD36; Coronary artery disease; ox LDL; rs1761667; rs3173798; Single nucleotide polymorphism

Indexed keywords

CD36 ANTIGEN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; MESSENGER RNA;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CD36 GENE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY AND SPECIFICITY; YOUDEN INDEX; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; CHINA; ETHNOLOGY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK FACTOR; STATISTICAL MODEL;

AGED; ANTIGENS, CD36; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CORONARY ARTERY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIPOPROTEINS, LDL; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER;

EID: 84907574956     PISSN: None     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20143825     Document Type: Article

References (22)

1. Pu J, Mintz GS, Biro S, Lee JB, Sum ST, Madden SP, et al. Insights into echo-attenuated plaques, echolucent plaques, and plaques with spotty calcification: novel findings from comparisons among intravascular ultrasound, near-infrared spectroscopy, and pathological histology in 2294 human coronary artery segments. J Am Coll Cardiol 2014; 63: 2220-2233, doi: 10.1016/j.jacc.2014.02.576.
2. Pu J, Mintz GS, Brilakis ES, Banerjee S, Abdel-Karim AR, Maini B, et al. In vivo characterization of coronary plaques: novel findings from comparing greyscale and virtual histology intravascular ultrasound and near-infrared spectroscopy. Eur Heart J 2012; 33: 372-383, doi: 10.1093/eurheartj/ehr387.
3. Kessler T, Erdmann J, Schunkert H. Genetics of coronary artery disease and myocardial infarction -2013. Curr Cardiol Rep 2013; 15: 368, doi: 10.1007/s11886-013-0368-0.
4. Collot-Teixeira S, Martin J, McDermott-Roe C, Poston R, McGregor JL. CD36 and macrophages in atherosclerosis. Cardiovasc Res 2007; 75: 468-477, doi: 10.1016/j.cardiores.2007.03.010.
5. Zhou Q, Wang ML, He SH, et al. Changes of the CD36 expression in peripheral blood monocytes in coronary heart disease, hypercholesterolemia and diabetes mellitus. Int J Lab Med 2007; 28: 769-771.
6. Lei J, Luo ZF, Wei J, et al. Correlation between CD36 level of monocyte and the severity of coronary artery atherosclerosis. Chin J Clinicians (Electronic Edition) 2009; 3: 1293-1298, http://www.clinicmed.cn/upload/pdf/200909/ 20090904042355372.pdf.
7. Gautam S, Banerjee M. The macrophage Ox-LDL receptor, CD36 and its association with type II diabetes mellitus. Mol Genet Metab 2011; 102: 389-398, doi: 10.1016/j.ymgme.2010.12.012.
8. Rac ME, Safranow K, Rac M, Kurzawski G, Krzystolik A, Sagasz-Tysiewicz D, et al. CD36 gene is associated with thickness of atheromatous plaque and ankle-brachial index in patients with early coronary artery disease. Kardiol Pol 2012; 70: 918-923.
9. Rac M, Safranow K, Kurzawski G, Krzystolik A, Chlubek D. Is CD36 gene polymorphism in region encoding lipid-binding domain associated with early onset CAD? Gene 2013; 530: 134-137, doi: 10.1016/j.gene.2013.06.061.
10. Banerjee M, Gautam S, Saxena M, et al. Association of CD36 gene variants rs1761667(G.A) and rs1527483(C.T) with Type 2 diabetes in North Indian population. Int J Diabetes Mellit 2010; 2: 179-183, doi: 10.1016/j.ijdm.2010.08.002.
11. Noel SE, Lai CQ, Mattei J, Parnell LD, Ordovas JM, Tucker KL. Variants of the CD36 gene and metabolic syndrome in Boston Puerto Rican adults. Atherosclerosis 2010; 211: 210-215, doi: 10.1016/j.atherosclerosis.2010.02.009.
12. Ma X, Bacci S, Mlynarski W, Gottardo L, Soccio T, Menzaghi C, et al. A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum Mol Genet 2004; 13: 2197-2205, doi: 10.1093/hmg/ddh233.
13. Honda S, Bessho H, Kondo N, Kusuhara S, Tsukahara Y, Negi A. Positive association of CD36 gene variants with the visual outcome of photodynamic therapy in polypoidal choroidal vasculopathy. Mol Vis 2012; 18: 2796-2804.
14. Ministry of Health CDPRC. Prevention of cardiovascular diseases in China report 2011. Beijing: Encyclopedia of China Publishing House; 2012.
15. Pu J, Yuan A, Shan P, Gao E, Wang X, Wang Y, et al. Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/ reperfusion injury. Eur Heart J 2013; 34:1834-1845, doi: 10.1093/eurheartj/ehs011.
16. Teupser D, Mueller MA, Koglin J, Wilfert W, Ernst J, von Scheidt W, et al. CD36 mRNA expression is increased in CD14+ monocytes of patients with coronary heart disease. Clin Exp Pharmacol Physiol 2008; 35: 552-556, doi: 10.1111/j.1440-1681.2007.04836.x.
17. Maiwald S, Zwetsloot PP, Sivapalaratnam S, Dallinga-Thie GM. Monocyte gene expression and coronary artery disease. Curr Opin Clin Nutr Metab Care 2013; 16: 411-417.
18. Keller KL, Liang LC, Sakimura J, May D, van Belle C, Breen C, et al. Common variants in the CD36 gene are associated with oral fat perception, fat preferences, and obesity in African Americans. Obesity 2012; 20: 1066-1073, doi: 10.1038/oby.2011.374.
19. Love-Gregory L, Sherva R, Sun L, Wasson J, Schappe T, Doria A, et al. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet 2008; 17: 1695-1704, doi: 10.1093/hmg/ddn060.
20. Rac ME, Suchy J, Kurzawski G, Kurlapska A, Safranow K, Rac M, et al. Polymorphism of the CD36 gene and cardiovascular risk factors in patients with coronary artery disease manifested at a young age. Biochem Genet 2012; 50: 103-111, doi: 10.1007/s10528-011-9475-z.
21. Koenig W, Karakas M, Zierer A, Herder C, Baumert J, Meisinger C, et al. Oxidized LDL and the risk of coronary heart disease: results from the MONICA/KORA Augsburg Study. Clin Chem 2011; 57: 1196-1200, doi: 10.1373/clinchem.2011.165134.
22. Kuriki K, Hamajima N, Chiba H, Kanemitsu Y, Hirai T, Kato T, et al. Relation of the CD36 gene A52C polymorphism to the risk of colorectal cancer among Japanese, with reference to with the aldehyde dehydrogenase 2 gene Glu487Lys polymorphism and drinking habit. Asian Pac J Cancer Prev 2005; 6: 62-68.